Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The company's main product, the EleGARD Patient Positioning System, has received FDA approval and optimizes patient positioning during CPR. Clinical studies and animal models have shown that controlled elevation of the head and thorax during active compression-decompression CPR with an impedance threshold device can significantly increase neurologically intact survival rates compared to conventional supine CPR. Each element of their HUP (Head Up Position) CPR approach has been FDA cleared and deemed safe to use.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Advanced CPR Solutions.